Phase 2a Exploratory, Randomized, Double-blind, Parallel-group Study of ONO-8577 Compared to Combination of Solifenacin Succinate/ Mirabegron for Overactive Bladder
Phase 2a Exploratory, Randomized, Double-blind, Parallel-group Study of ONO-8577 Compared to Combination of Solifenacin Succinate/ Mirabegron for Overactive Bladder
The objective of the study is to evaluate the efficacy and safety of ONO-8577 compared to combination of solifenacin succinate and mirabegron or placebo for overactive bladder
Inclusion Criteria:
Exclusion Criteria:
Bunkyo-ku, Tokyo, Japan
Edogawa-ku, Tokyo, Japan
Itabashi-ku, Tokyo, Japan
Nakano-ku, Tokyo, Japan
Nerima-ku, Tokyo, Japan
Setagaya-ku, Tokyo, Japan
Setagaya-ku, Tokyo, Japan
Shinagawa-ku, Tokyo, Japan
Shinagawa-ku, Tokyo, Japan
Suginami-ku, Tokyo, Japan